IMPACT RFA - Support Research to Reduce Prostate Cancer Mortality
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- _ You can learn more about this opportunity by visiting the funder's [website](https://www.cancer.org/content/dam/cancer-org/research/extramural-grants-documents/all-grant-policies.pdf).
Overview
Purpose
Prostate cancer is the second leading cause of cancer mortality among men in the United States. After decades of decline, the incidence of de novo metastatic prostate cancer diagnoses is increasing and alarmingly, Black men have more than twice as high a likelihood of death from prostate cancer than White men. The American Cancer Society (ACS) is committed to reducing the burden of prostate cancer and improving prostate cancer outcomes for all men by addressing its root causes.
To address the public health burden of prostate cancer, ACS has launched the IMPACT Initiative – Improving Mortality from Prostate CAncer Together. To bolster our strategic research efforts, ACS will fund research projects focused on reducing prostate cancer mortality and improving outcomes for all. Priority will be given to applications with direct relevance to reducing health disparities in prostate cancer mortality.
As part of our ongoing efforts, a consortium of IMPACT Investigators will meet annually to share research findings and facilitate collaborations.
Scientific Scope
Successful applications will propose studies with direct application to reducing prostate cancer mortality. Studies may span a variety of study designs and approach addressing mortality from any aspect. Possible research topics could include, but are not limited to:
- Increasing uptake of screening
- Healthy behaviors that reduce mortality in prostate cancer survivors
- Improving treatment outcomes in prostate cancer patients
- Developing novel targets for treatment
- Addressing risk factors for aggressive prostate cancers
- Increasing participation in clinical trials
Eligibility
Applications within the scope of this announcement will be accepted for all open ACS grant mechanisms (i.e., Postdoctoral Fellowships, Clinician Scientist Development Grants, Discovery Boost Grants, Research Scholar Grants). RSG applicants for this RFA initiative may be at any stage of career and any level of funding. All awarded applications will follow the same guidelines and terms as other ACS Grant applications unless specifically noted here.
Eligibility
_ You can learn more about this opportunity by visiting the funder's website.
What American Cancer Society Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 509
- Total given
- $23.09M
- Median grant
- $15K
- Range
- $5,648–$9.6M
- By dollars: District of Columbia 42%, Texas 7%, California 4%. Top recipient cities: New York, NY; Chicago, IL; Philadelphia, PA.
- 0% of grants with a stated purpose were for general or operating support.
- 14% of recipients were new grantees, not repeat recipients.
Example grants
American Cancer Society Cancer Action Network · Washington, DC
Program Support
$9.6M
U of TX MD Anderson Cancer Ctr · Houston, TX
Support/Research
$851K
Patient Advocate Foundation · Hampton, VA
Patient Support
$351K
Coriell Institute for Medical Research · Camden, NJ
Extramural Research Grant
$300K
Texas Oncology Foundation Inc · Dallas, TX
Patient Support
$213K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
- Health disparities
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
ACS - Fanconi Cancer Foundation Discovery Boost Grant
American Cancer Society Inc
Amount
More than US $135,000
Deadline
Deadline not published
Institutional Research Grants (IRG)
American Cancer Society Inc
Amount
Up to US $360,000
Deadline
Deadline not published
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 16, 2027
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
TheoryLab Collaborative (TLC) Grant
American Cancer Society Inc
Amount
Up to US $61,200
Deadline
Deadline not published
Discovery Boost Grants (DBG)
American Cancer Society Inc
Amount
Up to US $270,000
Deadline
Deadline not published
Ready to apply for IMPACT RFA - Support Research to Reduce Prostate Cancer Mortality?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found IMPACT RFA - Support Research to Reduce Prostate Cancer Mortality. Now let's win it.